About
Cortechs.ai specializes in AI-powered radiology applications designed to enhance patient care. Founded in 1996 and rebranded in 2020, the company focuses on improving disease detection, diagnosis, and treatment, particularly in neurology and oncology. Their mission is to merge advanced medical imaging with machine learning to pioneer precision health solutions. The company offers a comprehensive portfolio of regulatory-approved AI tools, including NeuroQuant, an automated brain volumetry platform for monitoring neurodegenerative diseases, and OnQ Prostate, which aids in prostate cancer detection. These tools provide fast, automated, and clinically validated imaging analyses that integrate seamlessly into existing clinical workflows, supporting various imaging vendors and scanner types. Cortechs.ai's technology is trusted by over 1,500 medical centers and hospitals across 44 countries, making it a preferred partner for healthcare institutions. The company has experienced growth through strategic mergers and partnerships, supported by a leadership team with extensive experience in medical imaging and AI development.
Technologies
Keywords
Company Information
-
Employees 58
-
Founded 2001
-
Annual Revenue $7098000
-
Total Funding $9071625
Location
5060 Shoreham Pl, San Diego, California, United States, 92122
